13.07
0.12 (0.93%)
Previous Close | 12.95 |
Open | 13.16 |
Volume | 13,587,258 |
Avg. Volume (3M) | 12,011,580 |
Market Cap | 8,906,290,176 |
Price / Earnings (TTM) | 12.57 |
Price / Earnings (Forward) | 12.77 |
Price / Sales | 1.34 |
Price / Book | 1.47 |
52 Weeks Range | |
Earnings Date | 24 Jul 2025 - 28 Jul 2025 |
Profit Margin | 10.70% |
Operating Margin (TTM) | 8.21% |
Diluted EPS (TTM) | 1.04 |
Quarterly Revenue Growth (YOY) | -5.90% |
Quarterly Earnings Growth (YOY) | 6.80% |
Total Debt/Equity (MRQ) | 67.34% |
Current Ratio (MRQ) | 1.12 |
Operating Cash Flow (TTM) | 808.50 M |
Levered Free Cash Flow (TTM) | 751.08 M |
Return on Assets (TTM) | 3.53% |
Return on Equity (TTM) | 12.52% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
Medical Instruments & Supplies (Global) | Bearish | Bearish | |
Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | 1.0 |
Insider Activity | NA |
Price Volatility | 1.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 0.5 |
Average | 0.75 |
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Mid Core |
% Held by Insiders | 1.32% |
% Held by Institutions | 103.16% |
Ownership
Name | Date | Shares Held |
---|---|---|
New Mountain Capital, L.L.C. | 31 Mar 2025 | 14,000,000 |
52 Weeks Range | ||
Price Target Range | ||
High | 22.00 (Wells Fargo, 68.32%) | Buy |
Median | 15.00 (14.77%) | |
Low | 14.00 (Goldman Sachs, 7.12%) | Hold |
14.00 (Stifel, 7.12%) | Hold | |
Average | 16.71 (27.85%) | |
Total | 4 Buy, 3 Hold | |
Avg. Price @ Call | 12.89 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Goldman Sachs | 29 Apr 2025 | 14.00 (7.12%) | Hold | 12.69 |
Baird | 28 Apr 2025 | 17.00 (30.07%) | Buy | 12.49 |
Barclays | 28 Apr 2025 | 15.00 (14.77%) | Buy | 12.49 |
10 Apr 2025 | 18.00 (37.72%) | Buy | 14.70 | |
Morgan Stanley | 28 Apr 2025 | 15.00 (14.77%) | Hold | 12.49 |
RBC Capital | 28 Apr 2025 | 20.00 (53.02%) | Buy | 12.49 |
Stifel | 28 Apr 2025 | 14.00 (7.12%) | Hold | 12.49 |
Wells Fargo | 17 Apr 2025 | 22.00 (68.32%) | Buy | 15.10 |
No data within this time range.
Date | Type | Details |
---|---|---|
27 Jun 2025 | Announcement | Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025 |
16 May 2025 | Announcement | Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference |
02 May 2025 | Announcement | Avantor® to Participate in Bank of America Securities 2025 Health Care Conference |
25 Apr 2025 | Announcement | Avantor® Announces CEO Transition |
25 Apr 2025 | Announcement | Avantor® Reports First Quarter 2025 Results |
01 Apr 2025 | Announcement | Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX |
28 Mar 2025 | Announcement | Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |